Biomedical informatics for proteomics

被引:147
作者
Boguski, MS
McIntosh, MW
机构
[1] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
关键词
D O I
10.1038/nature01515
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Success in proteomics depends upon careful study design and high-quality biological samples. Advanced information technologies, and also an ability to use existing knowledge to the full, will be crucial in making sense of the data. Despite its genome-scale potential, proteome analysis is at a much earlier stage of development than genomics and gene expression (microarray) studies. Fundamental issues involving biological variability, pre-analytic factors and analytical reproducibility remain to be resolved. Consequently, the analysis of proteomics data is currently informal and relies heavily on expert opinion. Databases and software tools developed for the analysis of molecular sequences and microarrays are helpful, but are limited owing to the unique attributes of proteomics data and differing research goals.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 70 条
  • [21] *CAMBR HEALTHT I, 2001, CAMBR HEALTHT I C HU
  • [22] CHAKRAVARTI DN, 2002, BIOTECHNIQUES, V32, pS4
  • [23] Chou SC, 2000, AUSTRALAS J AGEING, V19, P7
  • [24] Choudhary JS, 2001, PROTEOMICS, V1, P651, DOI 10.1002/1615-9861(200104)1:5<651::AID-PROT651>3.0.CO
  • [25] 2-N
  • [26] Craven RA, 2002, METHOD ENZYMOL, V356, P33
  • [27] Craven RA, 2001, PROTEOMICS, V1, P1200
  • [28] Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO
  • [29] 2-5
  • [30] DAYHOFF M O, 1970, Computers in Biology and Medicine, V1, P5, DOI 10.1016/0010-4825(70)90013-2